CR20200160A - Anti-cd3 antibodies and methods of use - Google Patents

Anti-cd3 antibodies and methods of use

Info

Publication number
CR20200160A
CR20200160A CR20200160A CR20200160A CR20200160A CR 20200160 A CR20200160 A CR 20200160A CR 20200160 A CR20200160 A CR 20200160A CR 20200160 A CR20200160 A CR 20200160A CR 20200160 A CR20200160 A CR 20200160A
Authority
CR
Costa Rica
Prior art keywords
antibodies
methods
differentiation
cluster
same
Prior art date
Application number
CR20200160A
Other languages
Spanish (es)
Inventor
Allen J Ebens Jr
Robert F Kelley
Mark S Dennis
Teemu T Junttila
Mary A Mathieu
Liping L Sun
Xiaocheng Chen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2014/070951 external-priority patent/WO2015095392A1/en
Publication of CR20200160A publication Critical patent/CR20200160A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The disclosure provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same.
CR20200160A 2013-12-17 2014-12-17 Anti-cd3 antibodies and methods of use CR20200160A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361917346P 2013-12-17 2013-12-17
US201461949950P 2014-03-07 2014-03-07
US201462026594P 2014-07-18 2014-07-18
PCT/US2014/070951 WO2015095392A1 (en) 2013-12-17 2014-12-17 Anti-cd3 antibodies and methods of use

Publications (1)

Publication Number Publication Date
CR20200160A true CR20200160A (en) 2020-05-23

Family

ID=71091792

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20200160A CR20200160A (en) 2013-12-17 2014-12-17 Anti-cd3 antibodies and methods of use

Country Status (2)

Country Link
CR (1) CR20200160A (en)
MY (1) MY192384A (en)

Also Published As

Publication number Publication date
MY192384A (en) 2022-08-18

Similar Documents

Publication Publication Date Title
ZA202206078B (en) Anti-cd3 antibodies and methods of use
MY191169A (en) Anti-fcrh5 antibodies
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2020002289A (en) ANTI-alpha-SYNUCLEIN ANTIBODIES AND METHODS OF USE.
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12015501954A1 (en) Anti-b7-h4 antibodies and immunoconjugates
MX2015012326A (en) Anti-crth2 antibodies and their use.
MX2017005920A (en) Anti-tim3 antibodies and methods of use.
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
MX2015013901A (en) Anti-il-4 antibodies and bispecific antibodies and uses thereof.
SG10201809668TA (en) Anti-her2 antibodies and immunoconjugates
MX2016012781A (en) Anti-ox40 antibodies and methods of use.
MX2013011479A (en) Anti-fgfr4 antibodies and methods of use.
MX2014004022A (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE.
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
MX354303B (en) Anti-biotin antibodies and methods of use.
MX2016004853A (en) ANTI-Ly6E ANTIBODIES AND METHODS OF USE.
MX357675B (en) Anti-jagged anitbodies and methods of use.
MX2014014381A (en) Anti-theophylline antibodies and methods of use.
MY192384A (en) Anti-cd3 antibodies and methods of use
MX2015010789A (en) Anti-mcsp antibodies.
AR117596A2 (en) ANTI-CD3 ANTIBODIES AND METHODS OF USE
CL2018002006A1 (en) Anti-cd3 antibodies and methods of use (divisional application 201601556)
EA201892257A1 (en) ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION